Regeneron Pharmaceuticals, Inc., listed on NASDAQ as REGN, is a prominent biotechnology company known for harnessing the potential of scientific innovation to develop groundbreaking medicines for individuals facing medical challenges.
With a focus on leveraging the power of science, Regeneron is dedicated to advancing new therapeutic solutions that address the unmet needs of patients, making significant contributions to the healthcare industry.
Generated from their website's infomation